Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.12% | 28.71% | 16.01% | 19.48% | 19.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.12% | 28.71% | 16.01% | 19.48% | 19.51% |
| Cost of Revenue | 25.98% | 39.44% | 18.69% | 16.41% | 26.09% |
| Gross Profit | 19.32% | 25.51% | 15.40% | 20.14% | 17.24% |
| SG&A Expenses | 53.62% | 5.69% | 14.83% | 17.10% | 3.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.01% | 39.93% | 0.56% | 25.25% | 13.51% |
| Operating Income | -30.81% | 6.12% | 125.60% | 8.09% | 38.64% |
| Income Before Tax | -27.42% | 8.56% | 128.81% | 10.41% | 41.49% |
| Income Tax Expenses | 173.56% | 3.41% | -2.40% | -13.63% | -48.94% |
| Earnings from Continuing Operations | -54.55% | 10.35% | 243.16% | 18.85% | 85.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.55% | 10.35% | 243.16% | 18.85% | 85.95% |
| EBIT | -30.81% | 6.12% | 125.60% | 8.09% | 38.64% |
| EBITDA | -25.46% | 5.58% | 97.56% | 6.97% | 33.19% |
| EPS Basic | -54.98% | 9.04% | 239.10% | 17.74% | 89.94% |
| Normalized Basic EPS | -28.10% | 7.27% | 126.14% | 9.38% | 44.53% |
| EPS Diluted | -55.05% | 10.13% | 240.00% | 16.42% | 89.84% |
| Normalized Diluted EPS | -28.01% | 7.43% | 125.38% | 8.67% | 43.04% |
| Average Basic Shares Outstanding | 0.94% | 1.20% | 1.17% | 0.95% | -2.10% |
| Average Diluted Shares Outstanding | 0.82% | 1.06% | 1.54% | 1.61% | -1.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |